Surgical and Pathological Outcomes of Abdominal Radical Trachelectomy Versus Hysterectomy for Early-Stage Cervical Cancer

医学 参数 根治性子宫切除术 旁体 气管切除术 宫颈癌 阶段(地层学) 病态的 淋巴结 外科 子宫切除术 泌尿科 癌症 内科学 生物 古生物学
作者
Dandan Zhang,Jin Li,Huijuan Ge,Xingzhu Ju,Xiaojun Chen,Jia Tang,Xiaohua Wu
出处
期刊:International Journal of Gynecological Cancer [BMJ]
卷期号:24 (7): 1312-1318 被引量:16
标识
DOI:10.1097/igc.0000000000000185
摘要

Objectives The aim of this study was to compare the surgical and pathological outcomes for patients with early-stage cervical cancer after abdominal radical trachelectomy (ART) and abdominal radical hysterectomy (ARH). Methods A prospective database of ART and ARH procedures performed in a standardized manner by the same surgical group was analyzed. The 3-segment technique was used for the accurate analysis of parametrial lymph nodes (PMLNs), and parametrial measurements were recorded by the same pathologist. Standard statistical tests were used. Result Between August 2012 and August 2013, ART was attempted in 39 patients (28.6%), and ARH was attempted in 90 patients (71.4%). The parametrium resection length was similar with ART and ARH (44.60 vs 45.48 mm, P = 0.432), as were additional surgical and pathological outcomes, including histology, lymph node positive rate, and operation time. The PMLNs were found in 28 patients (77.78%) in the ART group and in 86 (95.56%) in the ARH group ( P > 0.05). Solitary PMLN metastases were observed in 3 patients (10.71%) in the ART group and in 6 (6.98%) in the ARH group. Five (55.6%) of these 9 patients had tumors of 2 cm or greater. The ARH patients (36, 40.00%) were more likely to receive postoperative chemotherapy or radiation compared with ART patients (13, 33.33%; P = 0.017). At a median follow-up of 12 and 12.5 months ( P = 0.063), respectively, there were no recurrences or deaths in the ART or ARH groups. Conclusions Using standardized techniques, ART provides similar surgical and pathological outcomes as ARH. For the patients with tumors of 2 cm or greater, PMLNs should be examined carefully. Further prospective data are urgently needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
传奇3应助玉米豆采纳,获得10
1秒前
mufulee发布了新的文献求助80
2秒前
河边看水完成签到,获得积分10
3秒前
cs发布了新的文献求助10
3秒前
ivyjianjie发布了新的文献求助10
5秒前
櫹櫆完成签到 ,获得积分10
5秒前
ni完成签到 ,获得积分10
7秒前
bian完成签到 ,获得积分10
8秒前
小树叶完成签到 ,获得积分10
11秒前
11秒前
12秒前
Mrwang完成签到,获得积分10
14秒前
丁静完成签到 ,获得积分10
15秒前
huangxiaoniu完成签到,获得积分10
16秒前
周晓文发布了新的文献求助10
16秒前
Owen应助xx采纳,获得10
16秒前
务实豪发布了新的文献求助10
17秒前
18秒前
lineeeee完成签到,获得积分20
18秒前
cs完成签到,获得积分10
23秒前
丑123发布了新的文献求助10
24秒前
星辰大海应助cs采纳,获得10
27秒前
完美世界应助科研通管家采纳,获得10
29秒前
cdercder应助科研通管家采纳,获得10
29秒前
完美世界应助科研通管家采纳,获得10
29秒前
赘婿应助科研通管家采纳,获得10
29秒前
SciGPT应助科研通管家采纳,获得10
29秒前
FashionBoy应助科研通管家采纳,获得10
29秒前
英俊的铭应助科研通管家采纳,获得10
29秒前
JTHe应助科研通管家采纳,获得10
29秒前
FashionBoy应助科研通管家采纳,获得10
30秒前
wxl发布了新的文献求助10
30秒前
Can完成签到,获得积分10
40秒前
标致幻然完成签到 ,获得积分10
40秒前
高贵的往事完成签到 ,获得积分10
42秒前
点凌蝶完成签到,获得积分10
46秒前
眯眯眼的雪莲完成签到 ,获得积分10
47秒前
Growth完成签到 ,获得积分10
47秒前
Yang完成签到 ,获得积分10
49秒前
长安乱世完成签到 ,获得积分0
49秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Mindfulness and Character Strengths: A Practitioner's Guide to MBSP 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3776082
求助须知:如何正确求助?哪些是违规求助? 3321667
关于积分的说明 10206556
捐赠科研通 3036733
什么是DOI,文献DOI怎么找? 1666435
邀请新用户注册赠送积分活动 797459
科研通“疑难数据库(出版商)”最低求助积分说明 757841